(19)
(11) EP 4 798 576 A1

(12)

(43) Date of publication:
02.09.2026 Bulletin 2026/36

(21) Application number: 24883173.7

(22) Date of filing: 22.10.2024
(51) International Patent Classification (IPC): 
C07D 401/12(2006.01)
A61K 31/454(2006.01)
A61K 31/4453(2006.01)
C07D 295/26(2006.01)
A61K 31/4545(2006.01)
A61P 35/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/454; A61K 31/4453; A61P 35/00; C07D 295/26; C07D 209/30; C07D 209/08; C07D 235/06
(86) International application number:
PCT/US2024/052354
(87) International publication number:
WO 2025/090460 (01.05.2025 Gazette 2025/18)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 23.10.2023 US 202363545263 P

(71) Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Oakland, CA 94607-5200 (US)

(72) Inventors:
  • JUNG, Michael, E.
    Los Angeles, CA 90095-7191 (US)
  • PAJONK, Frank
    Los Angeles, CA 90095-7191 (US)
  • HE, Ling
    Los Angeles, CA 90095-7191 (US)
  • CHEN, Xiaohong
    Los Angeles, CA 90095-7191 (US)
  • DING, Hui
    Los Angeles, CA 90095-7191 (US)

(74) Representative: Vossius & Partner Patentanwälte Rechtsanwälte mbB 
Siebertstraße 3
81675 München
81675 München (DE)

   


(54) COMPOUNDS AND METHODS FOR TREATING CANCER